Blue Pavé

Blue Pavé

0 oogsten
hybrid
Genen
27%
THC
0.1%
CBD
Compound Genetics
Stam Creator
0 oogsten
hybrid
Genen
27%
THC
0.1%
CBD
Compound Genetics
Stam Creator

Blue Pavé is an indica-dominant hybrid created by crossing gassy and minty Pavé with clone-only Azul Runtz. This union resulted in a gorgeous cultivar known for its potency and complex flavor profile. Best for experienced users, THC levels average 23-27%. Its long-lasting effects start with a sustained stimulating cerebral effect, with an uplifted yet calm and creative head high. The deeply relaxed physical effects that follow are soothing before becoming a sleepy, sedative-like experience. The flavor profile coming from this cross is unique and complex with sweet and fruity blueberry and flowery notes, along with a distinct diesel funk and hints of sour orange citrus that some users report tastes similar to a chemical cleaner. When it comes to medical effects, this strain could be helpful for individuals with insomnia, stress, anxiety, lack of appetite, and chronic pain. As far as cultivation, it’s moderately difficult to grow. Flowering time is roughly 8-9 weeks. Yields are high with the right care — producing up to 650g/m2 indoors and up to 1200g/plant outdoors.

Show more
Positieve effecten:
Negatieve effecten:
Indica Sleepy
Sativa Energy
Laag THC Normaal
Hoge THC Krachtig

Stamboom


Blue Pavé Breeder products


Populaire Dagboeken Toon Alle Dagboeken

Blue Pave
14 weeks
Blue PaveRyno1990
Blue Pave
3y ago · 2 opmerkingen


Vergelijken met Blue Pavé

Type
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Hybrid
Cannabinoïde
THC 27%
THC 20%
THC 17%
THC 20.5%
THC 14.5%
THC 20%
THC 14%
THC 26%
THC 24%
THC 20%
Top Effect
Uplifted
Euphoric
Uplifted
Creative
Uplifted
Energetic
Euphoric
Uplifted
Creative
Relaxed
Dominante terpeen
Myrcene
Caryophyllene
Caryophyllene
Caryophyllene
Limonene
Caryophyllene
Caryophyllene
Caryophyllene
Caryophyllene
Caryophyllene

Harvested diaries Toon Alle Dagboeken

Blue Pave
14 weeks
Blue PaveRyno1990
Blue Pave
3y ago · 2 opmerkingen




Inloggen

Wees de eerste om het te reageren